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Abstract
Objective:  A  prospective,  randomized  and  double-blind  study  was  planned  to  identify  the  opti-
mum  dose  of  esmolol  infusion  to  suppress  the  increase  in  bispectral  index  values  and  the
movement  and  hemodynamic  responses  to  tracheal  intubation.
Materials  and  methods:  One  hundred  and  twenty  patients  were  randomly  allocated  to  one  of
three groups  in  a  double-blind  fashion.  2.5  mg  kg−1 propofol  was  administered  for  anesthesia
induction.  After  loss  of  consciousness,  and  before  administration  of  0.6  mg  kg−1 rocuronium,
a  tourniquet  was  applied  to  one  arm  and  inﬂated  to  50  mm  Hg  greater  than  systolic  pressure.
The  patients  were  divided  into  3  groups;  1  mg  kg−1 h−1 esmolol  was  given  as  the  loading  dose
and in  Group  Es50  50  g  kg−1 min−1,  in  Group  Es150  150  g  kg−1 min−1,  and  in  Group  Es250
250 g  kg−1 min−1 esmolol  infusion  was  started.  Five  minutes  after  the  esmolol  has  been  begun,
the  trachea  was  intubated;  gross  movement  within  the  ﬁrst  minute  after  orotracheal  intubation
was  recorded.
Results:  Incidence  of  movement  response  and  the  BIS  max  values  were  comparable  in  Group
Es250  and  Group  Es150,  but  these  values  were  signiﬁcantly  higher  in  Group  Es50  than  in  the
other  two  groups.  In  all  three  groups  in  the  1st  minute  after  tracheal  intubation  heart  rate  and
mean  arterial  pressure  were  signiﬁcantly  higher  compared  to  values  from  before  intubation
(p  <  0.05).  In  the  study  period  there  was  no  signiﬁcant  difference  between  the  groups  in  terms
of  heart  rate  and  mean  arterial  pressure.
Conclusion:  In  clinical  practise  we  believe  that  after  1  mg  kg−1 loading  dose,  150  g  kg−1 min−1
iv  esmolol  dose  is  sufﬁcient  to  suppress  responses  to  tracheal  intubation  without  increasing  side
effects.
©  2013  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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Efeito  de  diferentes  doses  de  esmolol  sobre  a  resposta  hemodinâmica,  BIS  e  resposta
de  movimento  durante  a  intubac¸ão  orotraqueal:  estudo  prospectivo,  randômico  e
duplo-cego
Resumo
Objetivo:  Estudo  prospectivo,  randômico  e  duplo-cego  planejado  para  identiﬁcar  a  dose  ideal
de  perfusão  de  esmolol  para  suprimir  o  aumento  dos  valores  do  BIS  e  os  movimentos  e  respostas
hemodinâmicas  à  intubac¸ão  traqueal.
Materiais  e  métodos: 120  pacientes  foram  randomicamente  alocados  um  dos  três  grupos,
usando o  método  duplo-cego.  Propofol  (2,5  mg  kg−1)  foi  administrado  para  induc¸ão  da  anestesia.
Após a  perda  da  consciência  e  antes  da  administrac¸ão  de  rocurônio  (0,6  mg  kg−1),  um  torniquete
foi aplicado  a  um  brac¸o e  insuﬂado  a  50  mm  Hg  acima  da  pressão  sistólica.  Os  pacientes  foram
divididos  em  três  grupos;  uma  dose  de  1  mg  kg−1 h−1 de  esmolol  foi  administrada  como  carga
e  perfusão  de  50  g  kg−1 min−1 de  esmolol  foi  iniciada  no  Grupo  ES50,  150  g  kg−1 min−1 no
Grupo Es150  e  250  g  kg−1 min−1 no  Grupo  ES250.  Cinco  minutos  após  o  início  da  perfusão,  a
traqueia  foi  intubada;  o  total  de  movimentos  no  primeiro  minuto  após  a  intubac¸ão  orotraqueal
foi  registrado.
Resultados:  A  incidência  da  resposta  de  movimentos  e  os  valores  máximos  de  BIS  foram  com-
paráveis nos  grupos  ES250  e  Es150,  mas  esses  valores  foram  signiﬁcativamente  mais  elevados
no  Grupo  ES50  que  nos  outros  dois  grupos.  Nos  três  grupos,  os  valores  de  frequência  cardíaca
e  pressão  arterial  média  foram  signiﬁcativamente  maiores  no  primeiro  minuto  pós-intubac¸ão,
comparados  aos  valores  pré-intubac¸ão  (p  <  0,05).  Não  houve  diferenc¸a signiﬁcativa  entre  os
grupos  em  relac¸ão  à  frequência  cardíaca  e  pressão  arterial  média  durante  o  período  de  estudo.
Conclusão:  Na  prática  clínica,  acreditamos  que  após  uma  dose  com  carga  de  1  mg  kg−1,  uma
dose de  150  g  kg−1 min−1 de  esmolol  IV  é  suﬁciente  para  suprimir  a  resposta  à  intubac¸ão
traqueal sem  aumentar  os  efeitos  colaterais.
©  2013  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  
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uring  anesthesia  induction  tracheal  intubation  is  one  of  the
ost intensive  noxious  stimuli  and  can  induce  hemodynamic
nd movement  responses  and  increase  the  bispectral  index
BIS).1--3 Hemodynamic  changes  due  to  tracheal  intubation,
imilar to  changes  due  to  other  surgery-related  stimuli  such
s anesthesia  and  skin  incisions,  are  often  transient.  How-
ver, in  patients  with  coronary  artery  disease,  hypertension
HT) or  with  a  history  of  cerebrovascular  disease,  a  possible
ncrease in  hemodynamic  parameters  may  cause  myocardial
schemia, arrhythmia,  infarction  or  cerebral  bleeding.1,2 The
lose relationship  of  tachycardiac  heart  rate  (HR)  to  myocar-
ial ischemia  has  suggested  the  use  of  -adrenergic  receptor
lockers for  the  suppression  of  the  hemodynamic  response
o tracheal  intubation.3--5
During  anesthesia  primarily  for  the  treatment  of  HT  and
achycardia 1 adrenoreceptor  antagonists  are  indicated,
hich have  been  proven  in  clinical  studies  to  have  a  role
n pain  modulation.6--13 While  the  mechanism  is  unknown,
smolol infusion  is  known  to  suppress  the  BIS  increase  and
ovement response  linked  to  tracheal  intubation  compared
o placebo.14,15 However  no  study  was  found  on  the  rela-
ionship between  the  effects  of  esmolol  at  different  infusion
oses. The  hypothesis  of  this  study  is  that  the  responses  to
racheal intubation  of  increased  movement  and  BIS  will  be
uppressed due  to  the  antinociceptive  effect  of  esmolol  in  a
ose-linked fashion,  causing  a  reduction  in  BIS  increase  and
ovement after  tracheal  intubation.  To  test  this  hypothesis
w
A
rnd  identify  the  optimum  infusion  dose  to  suppress  BIS
ncrease and  movement  response,  along  with  hemodynamic
esponse, to  tracheal  intubation,  a  prospective,  randomized
nd double-blind  study  was  designed.
ethods
fter  receiving  Dokuz  Eylül  University,  Faculty  of  Medicine
linical Trials  Local  Ethics  Committee  approval  and  informed
atient consent  this  prospective,  randomized,  double-blind
tudy was  completed.  One  hundred  and  twenty  adult
atients in  ASA  I--II  risk  groups,  between  the  ages  of  18  and
5, undergoing  elective  surgery,  apart  from  head,  neck  and
ardiac surgery,  were  enrolled  in  the  study.
Patients  with  predicted  difﬁcult  intubation  or  airway
anagement, body  mass  index  >  30  kg/m2,  HR  <  60  beats
in−1,  systolic  arterial  pressure  (SAP)  <  100  mm  Hg,  car-
iac diseases,  diabetes  mellitus,  renal  failure,  liver  failure,
OPD, asthma,  reactive  airway  disease,  symptomatic  gas-
roesophageal reﬂux,  patients  with  neuropsychiatric  or
eurological diseases,  pregnant  and  lactating  patients,
atients with  a  history  of  use  of  opioids,  tricyclic
ntidepressants,  benzodiazepines,  anticonvulsants,  cloni-
ine, -adrenergic  receptor  blockers,  or  alcohol  abuse,  and
atients with  a  history  of  allergic  reaction  to  the  study  drugs
ere excluded.
No drugs  were  administered  for  preoperative  medication.
nesthesia was  administered  after  18  G  intravenous  prepa-
ation of  10  mL  kg−1 0.9%  NaCl  with  ﬂuids  through  a  vascular
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Figure  1  Study  ﬂow  diagram.
access  cannula  opening.  After  being  taken  to  the  operating
table 6 L/min  oxygen  was  administered  through  a  mask.  In
all patients,  non-invasive  blood  pressure,  electrocardiogram
(ECG), pulse  oximetry,  and  esophageal  temperature  after
intubation were  monitored.  Baseline  values  for  HR,  non-
invasive mean  arterial  pressure  (MAP)  and  peripheral  oxygen
saturation (SpO2)  were  recorded.  After  standard  monitor-
ing, patients  were  monitored  with  the  A-2000  BIS  XP  device
(Aspect Medical  Systems,  Newton,  MA,  USA).  Measured  con-
trol BIS  values  were  recorded  after  contact  testing  was
completed.
After pre-oxygenation  to  induce  anesthesia  2.5  mg  kg−1
propofol  (1%  PropofolR,  Fresenius,  Austria)  was  applied  for
20 s  and  8  mg  kg−1 h−1 propofol  infusion  was  started.  After
loss of  eyelash  reﬂex  in  patients,  manual  end-tidal  CO2
(ETCO2)  35--40  mm  Hg  was  maintained  by  inhalation  of  100%
O2 through  the  mask  (Fig.  1).  Movement  response  to  tracheal
intubation was  assessed  by  the  isolated  forearm  technique.
For this  purpose,  after  loss  of  consciousness,  the  cuff  on  the
arm without  the  IV  was  inﬂated.  After  systolic  blood  pres-
sure of  50  mm  Hg  was  reached,  rocuronium  0.6  mg  kg−1 dose
was given  for  muscle  relaxation.16 After  5  min  of  infusion  of
propofol, all  patients  were  given  1  mg  kg−1 esmolol  (Brevi-
blocR Eczacıbas¸ı,  Baxter,  USA)  loading  dose  in  15  mL  total
volume 0.9%  NaCl  solution.  Patients  were  randomly  (sealed
envelope method)  allocated  to  three  groups  and  after  1  min,
study  medication  was  administered  by  an  anesthesiologist
aware of  the  medication  amount.  The  dose  was  calculated
for each  patient  by  a  50  mL  syringe  (10  mg/mL)  perfusor;
Group Es50  (n  =  40)  50  mg  kg−1 min−1 esmolol;  Group  Es150
(n =  40)  150  mg  kg−1 min−1 esmolol;  and  Group  Es250  (n  =  40)
250 mg  kg−1 min−1 infusion  of  esmolol.  After  5  min  of  esmolol
infusion, an  anesthesia  assistant  blind  to  the  amount  of
study drug  administered  intubated  the  patients.  Five  min-
utes after  intubation  esmolol  infusion  was  terminated.  In  the
study period,  anesthesia  was  maintained  with  8  mg  kg−1 h−1
infusion  of  propofol  and  50%  air--O2 mixture.  At  the  end  of
the study  period  anesthetic  management  responsible  for  the
operating theater  and  aware  of  the  amount  of  anesthetic
drugs applied  to  the  patients  left  the  team.
Before  induction  by  an  anesthesiologist  blind  to  the
amount of  study  drug  (control),  at  1st,  3rd  and  5th  minute
after the  start  of  propofol  infusion,  and  from  the  start
of esmolol  infusion  to  5  min  after  intubation  at  minute
intervals, HR,  MAP,  BIS,  and  SpO2 values  were  recorded.
After the  painful  stimulus  BIS  (difference  between  BIS
value pre-tracheal  intubation  and  after  5st  minute  post-
tracheal intubation)  and  BISmax  (difference  between  BIS
values pre-tracheal  intubation  and  maximum  value  within
5th minute  post-tracheal  intubation)  values  were  recorded
after intubation.16 The  time  between  the  opening  of  each
patient’s mouth  and  when  the  tracheal  tube  cuff  inﬂated
t
t
i
E427
as  deﬁned  as  the  intubation  time  and  was  recorded.
epeated intubation  attempts  and  patients  requiring  more
han 30  s  intubation  time  were  removed  from  the  study.
ithin 1  min  after  intubation  movement  of  the  patient’s  arm
he cuff  was  placed  on  was  accepted  as  a  positive  value  and
he air  sleeve  was  depressurized.
During  the  study  period,  for  hypotension
MAP  <  60  mm  Hg)  ﬁrst  the  intravenous  infusion  of  ﬂuid
as increased  and  if  no  improvement  within  5  min,  5  mg
f ephedrine  (Ephedrine,  Haver,  Istanbul,  Turkey)  was
dministered. For  bradycardia  (HR  <  50  beats  min−1) 0.5  mg
tropine (atropine  sulfate,  Haver,  Istanbul,  Turkey)  was
mplemented. Side  effects  including  hypotension,  brady-
ardia, arrhythmia,  cough,  hiccups,  increased  airway
esistance, bronchospasm,  etc.,  were  recorded.
After  1  h  in  the  recovery  unit  patients  were  asked  ques-
ions such  as  ‘‘Do  you  remember  any  event  from  beginning
r end  of  the  operation?’’  to  determine  awareness  of  intra-
perative events  and  responses  were  recorded.
ower  analysis
n  the  study  by  Menigaux  et  al.14 considering  change  in  BIS
alues, to  reach  80%  power  (˛  =  0.05)  each  group  should  con-
ain at  least  19  patients;  Guignard  et  al.17 revealed  that
1 patients  were  required  according  to  movement  response
ndings. The  three  groups  in  this  study  contained  a  total  of
20 patients  (n  =  40).
tatistics
ata  were  compiled  using  SPSS  11.0  for  Windows  program.
o determine  whether  parameters  had  normal  distribution
he Kolmogorov--Smirnov  test  and  box-plot  graphics  were
ompleted. To  compare  mean  values  between  the  3  groups
ne-way analysis  of  variance  (one-way  ANOVA)  and  post  hoc
ukey were  used.  Variations  within  groups  were  analyzed
sing the  paired-samples  t-test.  Non-parametric  data  were
nalyzed with  the  chi-square  test.  p  <  0.05  was  considered
tatistically signiﬁcant.
esults
etween  the  groups  there  was  no  difference  in  terms  of  age,
ody weight,  height,  sex,  ASA  risk  class  and  the  tracheal
ntubation duration.  Tracheal  intubation  was  performed  in
--14 s  (Table  1).  Two  patients  in  group  Es250  were  excluded
rom the  study  because  of  HR  <  60  beats  min−1 after  induc-
ion, and  1  patient  was  excluded  due  to  difﬁcult  intubation.
he data  from  a  total  of  117  patients  were  analyzed.
In  all  three  groups  after  propofol  induction  and  5  min
nfusion duration  there  was  no  signiﬁcant  difference  in  HR
ompared with  baseline.  From  the  second  minute  of  esmolol
nfusion until  before  tracheal  intubation,  the  HR  was  signif-
cantly decreased  according  to  the  baseline  (p  <  0.05)  in  all
 groups  (Fig.  2).  In  all  three  groups  in  the  1st  minute  after
racheal intubation  HR  was  signiﬁcantly  higher  compared
o values  from  before  intubation  (p  <  0.05).  After  propofol
nduction, in  Group  Es150  after  one  minute,  and  in  Group
s250 and  Group  Es50  after  3  min,  MAP  was  signiﬁcantly
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Table  1  Demographic  data  and  LTI  duration  (mean  ±  standard  deviation).
Group  Group  Es250
(n =  38)
Group Es150
(n =  39)
Group Es50
(n =  40)
Age  (year)  36.63  ±  10.55  40.12  ±  9.66  37.20  ±  9.01
Weight (kg)  67.16  ±  10.55  68.39  ±  12.23  66.90  ±  10.84
Height (cm) 168.37  ±  7.64  168.36  ±  8.47  166.75  ±  8.62
ASA (I/II) 37/1  39/0  40/0
Sex  (F/M) 27/11  27/12  30/10
LTI  duration  (s) 10.47  ±  1.47 10.89 ±  1.13 10.30 ±  1.02
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In  induction,  comparisons  have  been  made  on  theFigure  4  Changes  in  m
intubation  in  the  1st  and  2nd  minutes  BIS  values  in  all
three groups  showed  a  signiﬁcant  increase  compared  to
values from  before  tracheal  intubation  (p  <  0.05).  There
was no  signiﬁcant  difference  between  all  three  groups  in
terms of  BIS  values  during  the  study  period.  When  the
Groups are  compared  based  on  the  average  value  BIS
and BISmax  there  was  no  signiﬁcant  difference  between
Groups Es250  and  Es150,  but  both  groups  had  signiﬁcantly
lower values  than  Group  Es50  (p  <  0.05)  (Table  2).  Compar-
ing the  groups  in  terms  of  movement  response  to  tracheal
intubation, there  was  no  signiﬁcant  difference  between
Group Es250  (50%)  and  Group  Es150  (56%)  but  Group  Es50
(87.5%) was  signiﬁcantly  higher  than  the  other  two  groups
(Table 3).
No hypotension,  bradycardia,  arrhythmia,  cough,  hiccup,
bronchospasm, or  increased  airway  resistance  was  observed
in any  patient.  None  of  the  patients  indicated  any  intraop-
erative awareness  in  the  postoperative  period.  BIS,  HR  and
MAP during  the  pre-induction  period  were  also  similar  in  all
3 groups.
s
b
Table  2  Average  change  in  BIS.
Group  Group  Es250  (n  =  38)  
BIS  2.86  ±  2.64a
BISmax 4.73  ±  4.37a
a p < 0.05 (compared to Group Es50)
Table  3  Motion  response  in  the  groups.
Group  Group  Es250  (n  =  38)  
Movement  19  (50%)a
No movement  19  (50%)a
a p < 0.05 (compared to Group Es50).IS  values  in  the  groups.
iscussion
his  study  shows  that  in  patients  anesthetized  with  propofol,
smolol suppressed  awareness  reactions,  shown  by  move-
ent and  BIS,  to  tracheal  intubation,  in  a dose-linked
ashion.
Due to  the  short  active  duration  of  esmolol,  bolus  and
nfusion protocol,  constant  plasma  concentration  and  tra-
heal intubation  with  anesthetic  agents  were  chosen  to
ssess more  clearly  the  effect  on  BIS  values,  hemody-
amic and  movement  response.  Group  Es250  were  given  an
nfusion dose  known  in  the  literature  to  suppress  the  BIS
esponse;14,15 Group  Es150  were  given  a  dose  that  has  been
hown to  be  effective  in  the  treatment  of  intra-operative
T and  tachycardia18,19 and  Group  Es50  were  given  the  low-
st infusion  dose  proposed  to  suppress  the  hemodynamicuppression of  the  hemodynamic  response  to  tracheal  intu-
ation between  different  doses  of  esmolol,  as  infusion  or
Group  Es150  (n  =  39)  Group  Es50  (n  =  40)
2.89  ±  3.53a 9.25  ±  4.84
6.17  ±  6.85a 10.80  ±  5.48
Group  Es150  (n  =  39)  Group  Es50  (n  =  40)
22  (56.4%)a 35  (87.5%)
17  (43.6%)a 5  (12.5%)
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olus,  placebo  or  with  different  drug  groups  (nicardipine,
idocaine, alfentanil,  fentanyl,  etc.).18,21--27 Additionally,
o consensus  has  been  reached  on  the  optimum  dose,
dministration method  and  timing.2,3 In  a  meta-analysis
tudy evaluating  the  effectiveness  of  esmolol  on  hemody-
amic changes  induced  by  tracheal  intubation  by  Figueredo
nd Garcia-Fuentes,2 esmolol  suppressed  the  adrenergic
esponse to  tracheal  intubation  independent  of  dose  and
t was  reported  that  after  a  loading  dose  of  500  g  kg−1,
ithin 4  min  200--300  g  kg−1 min−1 continuous  infusion  dose
as the  most  efﬁcient  protocol.  Johansen  et  al.12 adminis-
ered propofol/N2O/morphine  anesthesia  with  esmolol  and,
eported a  dose-independent  slight  increase  in  HR  and  blood
ressure after  tracheal  intubation.  In  this  study,  similar
o previous  studies,  after  tracheal  intubation  in  all  three
roups an  increase  in  HR  and  MAP  independent  of  dose  was
ound compared  to  values  before  intubation  in  all  three
roups.2,12,14
A  short-term  effective  1 adrenergic  receptor  blocker,
NO-1101 in  increasing  infusion  doses,  signiﬁcantly  sup-
ressed the  SAP  increase  linked  to  tracheal  intubation,
owever it  was  reported  that  it  increased  the  incidence
f hypotension.28 Similarly,  Figueredo  and  Garcia-Fuentes2
n  a  meta-analysis  study,  found  esmolol  administered  with
nduction agents  and  especially  opioids,  caused  a dose-
inked increase  in  hypotension  and  bradycardia  incidence
efore tracheal  intubation.  Together  with  this  in  the  period
efore intubation  in  the  placebo  group  there  was  a  2.6%
eduction in  MAP  while  the  esmolol  group  had  a  10.1%
ecrease in  MAP.  Similarly  in  our  study,  in  all  three  groups,
he decline  in  MAP  from  the  beginning  of  propofol  infusion
ontinued after  addition  of  esmolol  infusion  until  the  period
rior to  tracheal  intubation.  Although  there  is  no  statisti-
ally signiﬁcant  difference  between  groups;  compared  with
aseline in  all  3  groups  before  tracheal  intubation  (Group
s250: 17%,  Group  Es150:  15%,  and  Group  Es50:  11.2%)  there
as a  signiﬁcant  decrease  in  MAP.  However  hypotension
MAP <  60  mm  Hg)  or  bradycardia  (HR  <  50  beats  min−1) was
ot observed  in  any  patient.
Many  studies  on  the  effect  of  esmolol  on  the  hemo-
ynamic response  to  tracheal  intubation  have  used
uccinylcholine as  a  muscle  relaxant.21--27 Administration
f propofol  with  succinylcholine  has  caused  signiﬁcant
radycardia29 and  fasciculations  due  to  succinylcholine  have
een suggested  to  have  an  adverse  affect  on  monitoring
IS.30 For  these  reasons  we  chose  rocuronium  in  our  study.
ocuronium’s vagolytic  effect31 may  have  prevented  the
xpected bradycardia  and  hypotension  due  to  propofol  and
smolol administration  and  contributed  to  ensuring  stable
emodynamics. This  situation  we  believe  is  additionally
ffected by  not  using  opioids  for  induction.
As  described  by  Prys  Roberts  and  Kissin,  to  determine
he depth  of  anesthesia,  voluntary  movement  response
o a  speciﬁc  type  of  painful  stimulus  is  the  most  appro-
riate concept.  Anesthesia  depth  is  a  pharmacodynamic
easurement  that  includes  the  interaction  of  the  two  med-
cation groups  (hypnotic  and  analgesic  agents)  that  form
he basis  of  clinical  anesthesia.32 Inhibition  of  the  cerebral
ortex by  hypnotics  results  in  clinical  loss  of  conscious-
ess and  reduction  in  BIS  values  (or  on  EEG).  The  basic
ffect of  analgesics  is  inhibition  of  the  subcortical  struc-
ures and  spinal  cord  weakening  the  communication  of
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ainful  stimuli  to  the  cortex.  As  a  result  clinical  con-
ciousness levels  and  movement  response  reduce.  In  spite
f the  sedative  effects  of  opioids  suppressing  the  cortex,
‘unconsciousness’’ is  only  formed  by  hypnotics  at  the  corti-
al level.  ‘‘Lack  of  response’’  is  formed  by  the  interactions
f analgesics  and  hypnotics  at  both  cortical  and  subcortical
evels.32
Guignard  et  al.17 in  patients  under  propofol  anesthe-
ia in  steady-state  conditions  found  that  in  the  absence
f painful  stimuli  remifentanyl  infusion  did  not  change  BIS
alues before  tracheal  intubation;  however  it  reduced  the
ncrease in  BIS  values  (BIS),  hemodynamic  and  movement
esponses to  tracheal  intubation  in  a  dose-linked  manner.
or this  reason  in  evaluating  the  analgesic  component  of
nesthesia after  painful  stimuli  they  concluded  BIS  values
ay be  as  sensitive  as  hemodynamic  changes.  Berkenstadt
t al.33 reported  that  bolus  administration  of  esmolol  did
ot change  BIS  values  in  the  absence  of  painful  stimuli.
enigaux et  al.14 in  patients  anesthetized  with  propofol
nd Oda  et  al.15 in  anesthesia  with  1 MAC  sevoﬂurane  with
smolol infusion,  similar  to  opioids,  found  there  was  no  sig-
iﬁcant effect  on  the  BIS  values  before  tracheal  intubation,
owever increase  in  BIS  values  linked  to  tracheal  intuba-
ion and  hemodynamic  response  and  movement  decreased.
awaguchi et  al.34 studied  short-term  effect  landiolol,  a
1 adrenoreceptor  antagonist,  during  steady  state  condi-
ions of  propofol  anesthesia,  and  similar  to  remifentanyl,
eported a  suppression  in  the  increased  entropy  response
response entropy  =  RE  and  situation  entropy  =  SE,  reﬂective
f nociceptive  and  hypnotic  levels  in  general  anesthesia)
o tracheal  intubation  in  the  form  of  nociceptive  response
E and  RE--SE  response  reductions.  In  our  study  similar  to
revious studies,14,15 in  the  absence  of  painful  stimuli  after
smolol infusion  and  before  intubation  there  was  no  reduc-
ion in  BIS  values  in  all  three  groups.  This  result  shows
hat in  the  absence  of  painful  stimuli  esmolol  does  not
ffect BIS  during  general  anesthesia.  Thus  it  can  be  said
hat esmolol  alone  has  no  anesthetic  effect.  In  contrast,
 steady-state  conditions  study  by  Johansen35 on  addi-
ion of  esmolol  infusion  to  propofol/alfentanil  anesthesia,
howed BIS  decreased  while  cerebral  cortical  activity  was
uppressed and  burst  suppression  was  caused.  However  this
tudy did  not  examine  surgical  stimuli  and  also  opioids  were
sed.
After esmolol  infusion  cortical  EEG  suppression  and
AC reduction  shows  that  esmolol  infusions  have  different
harmacologic effects  during  anesthesia,  because  cortical
uppression and  MAC  are  anatomically  separate  in  animals.35
fter  tracheal  intubation  in  Group  Es250  and  Group  Es150,
BIS values  and  incidence  of  movement  response  were
igniﬁcantly reduced  compared  to  Group  Es50.  Johansen
t al.  in  a  study  on  propofol/N2O  anesthesia  with  morphine
remedication reported  propofol’s  Cp50 values  (minimum
ffective plasma  concentration  to  suppress  movement  due
o skin  incision  in  50%  of  patients)  reduced  linked  to  dose
f esmolol  infusion.12 In  the  same  group,  esmolol  infusion
lone did  not  reduce  isoﬂourane  MAC  values  (the  concentra-
ion that  suppresses  movement  response  to  skin  incision  in
0% of  patients);  however  alfentanil  infusion  alone  caused
 dose-linked  reduction  in  MAC  values  (25%),  while  alfen-
anil infusion  with  high-dose  esmolol  added,  increased  MAC
alues (43%).12 In  both  these  studies  opioids,  known  to
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affect  movement  response  were  used,  and  the  movement
response to  the  more  submaximal  painful  stimuli  of  skin
incision, compared  to  tracheal  intubation,  was  evaluated.
It is  not  possible  to  deﬁnitively  comment  on  the  effect
of esmolol  on  the  movement  response  to  painful  stimuli
based on  these  two  studies.  The  results  of  the  present
study are  in  accordance  with  those  of  previous  studies,14,15
though  the  effect  of  esmolol  on  BIS  and  movement  response
is shown  to  be  dose  linked.  During  propofol  anesthesia
in the  absence  of  painful  stimuli  esmolol  does  not  affect
BIS and  in  the  presence  of  painful  stimuli  suppresses  BIS
values and  movement  response  in  a  dose-linked  manner,
affecting BIS  value  increases  and  movement  response  to
tracheal intubation  in  a  similar  manner  to  esmolol  and
opioids.14,15,17
The  mechanism  behind  the  effect  of  esmolol  on  BIS
and movement  response  is  not  clear.  The  ﬁrst  mecha-
nism proposed  to  explain  this  effect  is  that  esmolol  has
a central  anti-nociceptive  effect.  Another  mechanism  may
be  pharmacokinetic  interactions  with  propofol  and/or  opi-
oids.
Painful  stimuli  travel  through  the  spinal  cord  to  the
brain stem,  reticular  formation  and  thalamus  and  from
there are  transmitted  to  the  cerebral  cortex  where  the  EEG
response forms.8,14 -Adrenergic  receptors  are  known  in  var-
ious regions  of  the  reticular  activating  system  and  basal
forebrain, especially  in  the  medial  septal.  In  this  region,  -
adrenoceptor agonist  infusion  increases  EEG  activity  and  the
behavioral symptoms  of  wakefulness  in  animals;  in  contrast
-adrenoceptor antagonist  infusion  is  shown  to  suppress
the EEG  response.14 Speciﬁc  1-adrenoceptor  antagonist,
ONO-1101, was  reported  to  reduce  the  pain  behavior  after
intrathecal injections  of  formalin.14 Clinical  studies  show
esmolol changes  EEG  response  to  painful  stimuli  and  reduces
the increase  in  BIS.14,15 This  brings  to  mind  the  possibil-
ity that  esmolol’s  effects  on  BIS  may  be  similar  to  the
reduction in  -adrenoceptor  block  due  to  pain  response
increasing central  catecholamine  concentration.  However,
the fact  that  short-acting  esmolol  is  hydrophilic  and  cannot
pass the  blood--brain  barrier  does  not  fully  support  this  idea.
Therefore, further  studies  are  needed  on  the  role  of  esmolol
in central  modulation  of  pain.
The  other  mechanism  to  explain  the  effect  of  esmolol  on
BIS and  movement  response  is  pharmacokinetic  interactions
with propofol  and/or  opioids.11,12 Johansen,  in  steady-state
conditions propofol/alfentanil  anesthesia,  found  that  while
esmolol  infusion  did  not  affect  the  plasma  concentrations
of propofol  and  alfentanil  or  pharmacokinetics,  BIS  val-
ues decreased  and  reversible  burst  suppressions  occurred.35
Orme  et  al.36 found  esmolol  infusion  did  not  signiﬁcantly
reduce propofols  Cp50-awake value  or  change  the  plasma
concentration  of  propofol.  We  did  not  use  opioids  in  our
study. However  as  propofol  concentration  was  not  measured
we cannot  eliminate  potential  pharmacokinetic  interactions
with esmolol.  In  light  of  these  data  the  mechanism  for
esmolol’s effects  on  BIS  and  the  movement  response  is  not
fully understood.
In conclusion,  in  patients  anesthetized  with  propofol
250 and  150  g  kg−1 min−1 esmolol  infusion  after  1  mg  kg−1loading  dose  reduce  the  increase  in  BIS  values  and  the
movement response  linked  to  tracheal  intubation  in  a  dose-
linked manner  compared  to  50  g  kg−1 min−1 iv  infusion.
1431
onsidering  the  results  of  this  study,  it  is  concluded  that  in
linical practise  to  suppress  the  responses  to  tracheal  intu-
ation 1  mg  kg−1 loading  dose  followed  by  150  g  kg−1 min−1
v  esmolol  infusion  may  be  used  without  increasing  dose-
inked side  effects.37
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